
CAS 1097917-15-1
:ASP-3026
Description:
ASP-3026, with the CAS number 1097917-15-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is primarily investigated for its role as a selective inhibitor of certain enzymes or pathways involved in disease processes. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. ASP-3026 has been studied for its efficacy in treating conditions such as cancer, where it may target specific tumor types or mechanisms of resistance. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), are crucial for determining its suitability as a therapeutic agent. Additionally, safety and toxicity profiles are essential considerations in the development of ASP-3026, as they influence dosing regimens and potential side effects. Ongoing research aims to elucidate its full therapeutic potential and optimize its use in clinical settings.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS:Formula:C29H40N8O3SPurity:%Color and Shape:SolidMolecular weight:580.7447N2-(2-(Isopropylsulfonyl)Phenyl)-N4-(2-Methoxy-4-(4-(4-Methylpiperazin-1-Yl)Piperidin-1-Yl)Phenyl)-1,3,5-Triazine-2,4-Diamine
CAS:N2-(2-(Isopropylsulfonyl)Phenyl)-N4-(2-Methoxy-4-(4-(4-Methylpiperazin-1-Yl)Piperidin-1-Yl)Phenyl)-1,3,5-Triazine-2,4-DiaminePurity:98+%Molecular weight:580.74g/molASP3026
CAS:ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies,and Positive for Anaplastic Lymphoma Kinase.Formula:C29H40N8O3SPurity:98.78% - 99.81%Color and Shape:SolidMolecular weight:580.74ASP3026
CAS:<p>ASP3026 is a selective tyrosine kinase inhibitor, which is a synthetic small molecule derived from advanced pharmaceutical research. Its mode of action involves the selective inhibition of the anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase implicated in a variety of cancers. By blocking the activity of ALK, ASP3026 interferes with critical signaling pathways that are essential for cancer cell proliferation and survival.</p>Formula:C29H40N8O3SPurity:Min. 95%Molecular weight:580.75 g/mol




